Sponsor or institution

Clinical trials and research at Beijing Tongren Hospital

• 23Clinical trials
• 1New in 30 days
• 1Country

Newest trials

All recruiting trials (23)

• Entinostat for pediatric soft tissue sarcoma with PAX abnormalities

  This study tests entinostat, alone or with chemotherapy, in children whose soft tissue sarcomas have PAX-family gene abnormalities to see if it can help shrink tumors or slow progression.

  Recruiting Phase 1 Beijing Tongren Hospital · Beijing, Beijing Municipality · NCT07888114

• Hyperopic reserve screening for kindergartners in Beijing

  A population-wide screening tests whether senior kindergarten children in Beijing have enough hyperopic reserve to help prevent future myopia.

  Recruiting Beijing Tongren Hospital · Beijing · NCT07851532

• Efgartigimod for Anti-NMDA Receptor Encephalitis

  This study tests whether efgartigimod, given IV weekly for 4 weeks, helps adults with anti-NMDA receptor encephalitis see improvements in daily function.

  Recruiting Phase 2 Beijing Tongren Hospital · Beijing · NCT07822776

• MEPL-G combination therapy for NK/T‑cell lymphoma with HLH

  This trial will test whether the MEPL-G drug combination (liposomal mitoxantrone, etoposide, pegaspargase, methylprednisolone, and golidocitinib) can control both the lymphoma and the life‑threatening HLH inflammation in adults with NK/T‑cell lymphoma–associated HLH.

  Recruiting Phase 1/2 Beijing Tongren Hospital · Beijing · NCT07525466

• Pomalidomide, anti–PD‑1 antibody, and selinexor for relapsed/refractory primary CNS diffuse large B‑cell lymphoma

  This trial tests whether combining pomalidomide, a PD‑1 blocking antibody, and selinexor can help adults with relapsed or refractory primary central nervous system diffuse large B‑cell lymphoma.

  Recruiting Phase 2 Beijing Tongren Hospital · Beijing, Beijing Municipality · NCT07523737

• Absorbable drug-eluting lacrimal sac stent for recurrent chronic dacryocystitis

  This study tests whether an absorbable, mometasone-coated lacrimal sac stent placed during a standard endoscopic procedure can help keep the tear duct open and reduce inflammation in people with recurrent chronic dacryocystitis.

  Recruiting Phase 2 Beijing Tongren Hospital · Beijing, Beijing Municipality and 1 other locations · NCT07499791

• Zanubrutinib plus Pola-R-CHP for newly diagnosed high-risk diffuse large B‑cell lymphoma

  This tests whether adding the BTK inhibitor zanubrutinib to a Pola-R-CHP regimen helps people with newly diagnosed DLBCL who have high-risk features.

  Recruiting Phase 2 Beijing Tongren Hospital · Beijing, Beijing Municipality · NCT07371923

• Orelabrutinib alone or with a CD20 antibody for people newly diagnosed with marginal zone lymphoma

  This trial tests if orelabrutinib by itself or together with a CD20 antibody can treat adults who have just been diagnosed with marginal zone lymphoma.

  Recruiting Phase 4 Beijing Tongren Hospital · Beijing and 2 other locations · NCT07355699

• Diverse-segment defocus spectacle lenses to slow childhood myopia

  This study will test whether two different diverse-segment defocus optimization (D.S.D.O.) spectacle lens designs can slow myopia progression in children aged 6–14.

  Recruiting Beijing Tongren Hospital · Beijing · NCT07323251

• Finotonlimab plus Stapokibart for recurrent or metastatic head and neck cancer

  This trial will see if combining Finotonlimab with Stapokibart helps adults with recurrent or metastatic head and neck squamous cell carcinoma who progressed after PD‑1 therapy.

  Recruiting Phase 1 Beijing Tongren Hospital · Beijing, Beijing Municipality · NCT07040072

• Laser acupuncture treatment for Bell's palsy

  This study is testing if laser acupuncture can help people with Bell's palsy feel better compared to standard treatments and a fake treatment.

  Recruiting Beijing Tongren Hospital · Beijing, Beijing Municipality · NCT06732622

• Combining chemotherapy, radiotherapy, and immunotherapy for advanced head and neck cancer

  This study is testing a new treatment that combines chemotherapy, radiation, and immunotherapy for patients with advanced head and neck cancer who can't have surgery to see if it helps them live longer and feel better.

  Recruiting Phase 2 Beijing Tongren Hospital · Beijing, Beijing Municipality · NCT06725498

• Treatment of refractory anti-NMDAR and anti-LGI1 encephalitis with Taitacept

  This study is testing if adding Taitacept to regular treatments can help people with tough cases of anti-NMDAR and anti-LGI1 encephalitis feel better.

  Recruiting Phase 2 Beijing Tongren Hospital · Beijing, Beijing Municipality · NCT06510283

• Understanding factors affecting eye health in children

  This study looks at what affects eye health in kids aged 6-9 to see how certain factors might help prevent nearsightedness from getting worse.

  Recruiting Beijing Tongren Hospital · Beijing, Beijing Municipality · NCT06498947

• Evaluating fluid therapy for recovery after head and neck cancer surgery

  This study is testing if a special way of giving fluids during surgery can help people recover better after having head and neck cancer surgery.

  Recruiting Beijing Tongren Hospital · Beijing, Beijing Municipality · NCT06468852

• Combination treatment for advanced NK/T-cell lymphoma

  This study is testing a new combination treatment for people with advanced NK/T-cell lymphoma to see if it is safe and effective.

  Recruiting Phase 1/2 Beijing Tongren Hospital · Beijing, Beijing Municipality · NCT06376721

• CM310 for uncontrolled seasonal allergic rhinitis

  This trial will try CM310, a medicine that blocks the interleukin‑4 receptor, in people whose seasonal allergic rhinitis is not well controlled by current treatments.

  Recruiting Phase 2 Beijing Tongren Hospital · Beijing, Beijing Municipality · NCT06300203

• Combining Pembrolizumab with Chemotherapy for Advanced Head and Neck Cancer

  This study is testing whether adding a drug called pembrolizumab to standard chemotherapy can help people with advanced head and neck cancer respond better to treatment.

  Recruiting Phase 3 Beijing Tongren Hospital · Beijing, Beijing Municipality · NCT06102395

• Combining PD-1 therapy with chemotherapy for advanced head and neck cancer

  This study is testing if combining a new cancer treatment with chemotherapy can help people with advanced head and neck cancer feel better and have better outcomes.

  Recruiting Phase 2 Beijing Tongren Hospital · Beijing, Beijing Municipality · NCT06100497

• Bispecific CAR-T cell therapy for relapsed B-cell cancers

  This study is testing a new type of CAR-T cell therapy that targets two cancer markers to see if it helps people with relapsed B-cell cancers feel better and have better outcomes.

  Recruiting Phase 2 Beijing Tongren Hospital · Beijing, Beijing Municipality · NCT06081478

• Using AI to diagnose retinal diseases in real-world settings

  This study is testing whether an AI program can accurately diagnose retinal diseases like diabetic retinopathy and age-related macular degeneration using pictures of the retina taken by trained operators.

  Recruiting Beijing Tongren Hospital · Beijing, Beijing Municipality · NCT05981950

• Examining retinal blood vessels in patients with common internal diseases using advanced imaging

  This study is trying to see how conditions like high blood pressure, diabetes, and high cholesterol affect the blood vessels in the eyes over five years using advanced imaging technology.

  Recruiting Beijing Tongren Hospital · Beijing, Beijing Municipality · NCT05644548

• Transplanting stem cells to treat macular degeneration

  This study is testing if using a patient's own stem cells to create new eye cells can help treat age-related macular degeneration in people aged 50 to 75.

  Recruiting Phase 1 Beijing Tongren Hospital · Beijing, Beijing Municipality · NCT05445063

Quick answers

How many clinical trials run by Beijing Tongren Hospital are recruiting right now?

23, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 9, Phase 1: 3, Phase 1/2: 2, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →